Clinical Trials Browser

INDUSTRY × rovalpituzumab tesirine × Dermatologic × Clear all

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Mesothelioma, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Carcinoma, Merkel Cell, Cholangiocarcinoma, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT02709889 2020-10-19

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

Phase 1/2 Terminated

200 enrolled 21 charts

CNSDermatologic

Glioblastoma, Melanoma, Carcinoma, Medullary

Clinical Trials

A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors